With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Critical Contributions of CRM1 to Leukemogenesis||University of Vermont / Jessica Linda Heath, MD||Young Investigator Grants||2015||Vermont|
|Phase I and II Clinical Research Program Infrastructure Award||University of Minnesota / Brenda Weigel, MD & Emily Greengard MD||Phase I/II Infrastructure Grants||2015||Minnesota|
|Identifying Mechanisms of Glucocorticoid Resistance in Pediatric Acute Lymphoblastic||University of Massachusetts Medical School / Michelle Kelliher, PhD||Innovation Grants||2015||Massachusetts|
|Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors||University of Florida / Catherine Flores, PhD||Young Investigator Grants||2015||Florida|
|Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas||University of California, Davis Medical Center / Paul Knoepfler, PhD||Innovation Grants||2015||California|
|Targeting the LIN28 Pathway in ATRT||The Johns Hopkins University School of Medicine / Eric Raabe, MD, PhD||'A' Award Grants||2015||Maryland|
|The Cebpa Downstream Enhancer as a Key Target of Transformation to Acute Myeloid Leukemia||The Johns Hopkins University School of Medicine / Stacy Cooper, MD||Young Investigator Grants||2015||Maryland|
|Developing a Novel Tumor Model to Screen for New Therapies for Spinal Ependymoma||The Johns Hopkins University School of Medicine / Linda Resar, MD & Richard Schlegel, MD, PhD||Innovation Grants||2015||Maryland|
|Molecular Annotation for Treatment of Childhood Cancers Trial: Neuroblastoma (MATCH-NB)||Children's Hospital of Philadelphia / Yael Mosse, M.D.||Bio-Therapeutic Impact Award||2015||Pennsylvania|
|CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma||Children's Hospital of Philadelphia / Robyn Sussman, PhD||Young Investigator Grants||2015||Pennsylvania|